To further elucidate the function of BTBD9 and TNFAIP1 in lung cancer, the CRISPR/Cas9 system was used to knockdown BTBD9 or TNFAIP1 individually and simultaneously (Fig. 4a, b). This evidence concerns the gene TNFAIP1 and lung cancer.